文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

联合驻点桥接康复计划对阿片类使用障碍患者住院时长的影响:BRIDGE随机临床试验

Effect of a Co-Located Bridging Recovery Initiative on Hospital Length of Stay Among Patients With Opioid Use Disorder: The BRIDGE Randomized Clinical Trial.
PubMed 文献 · JAMA Netw Open · 2024-02-05
一句话结论对阿片类使用障碍住院患者,桥接诊所转介未缩短住院时长,虽改善门诊衔接与复方取药并减少过量,但再入院与费用更高。

这项平行组随机临床试验在2019年11月25日至2021年9月28日于一家大型学术医学中心附属三级医院及其桥接诊所招募335例成人阿片类使用障碍住院患者,均有成瘾咨询会诊且无现有门诊美沙酮/丁丙诺啡等MOUD处方医生。干预组接受出院前后强化个案管理、MOUD处方及转介至联合驻点桥接诊所;常规组接受MOUD处方并转介至社区MOUD医生。主要终点住院时长无差异(AOR 0.94,95%CI 0.65-1.37;P=0.74)。16周时桥接组无住院天数更少、再入院更多、费用更高,但门诊衔接和MOUD续方更好、过量更少;急诊就诊和死亡无差异。

要点

  • 335例阿片类使用障碍住院患者随机分入桥接诊所组(167例)与常规组(168例),主要终点住院时长无差异:AOR 0.94(95%CI 0.65-1.37),P=0.74。
  • 16周随访时桥接组再入院更多(AOR 2.17,95%CI 1.25-3.76)、无住院天数更少(AOR 0.54,95%CI 0.32-0.92)、费用更高(AOR 2.25,95%CI 1.51-3.35)。
  • 桥接组更可能衔接至MOUD处方医生(AOR 2.37,95%CI 1.32-4.26)、MOUD续方更多(AOR 6.17,95%CI 3.69-10.30),过量更少(AOR 0.11,95%CI 0.03-0.41)。
  • 急诊就诊(AOR 1.15,95%CI 0.68-1.94)与死亡(AOR 0.48,95%CI 0.08-2.72)在两组间无差异。
  • 16周随访电话仅完成88例(26.3%),门诊指标解释需谨慎。

适用人群与场景

  • 成人住院阿片类使用障碍患者,由成瘾咨询会诊接诊且无现有门诊医生提供MOUD,招募于2019年11月25日至2021年9月28日在一家大型学术医学中心附属三级医院及其桥接诊所。

处置流程与药物剂量

  • 桥接诊所干预包括出院前后强化个案管理、MOUD处方和转介至联合驻点桥接诊所。
  • 常规 care 包括MOUD处方和转介至提供MOUD的社区卫生保健人员。

研究设计与关键结果

  • 研究类型:平行组随机临床试验,样本量335例(桥接组167例,常规组168例),单中心(一家三级医院及其桥接诊所),人群为成人阿片类使用障碍住院患者。
  • 主要终点:住院时长中位数两组无差异(AOR 0.94,95%CI 0.65-1.37;P=0.74)。
  • 16周次要终点:桥接组无住院天数更少(AOR 0.54,95%CI 0.32-0.92)、再入院更多(AOR 2.17,95%CI 1.25-3.76)、费用更高(AOR 2.25,95%CI 1.51-3.35),急诊就诊无差异(AOR 1.15,95%CI 0.68-1.94)、死亡无差异(AOR 0.48,95%CI 0.08-2.72)。
  • 桥接组更可能衔接至MOUD处方医生(AOR 2.37,95%CI 1.32-4.26)、MOUD续方更多(AOR 6.17,95%CI 3.69-10.30)、过量更少(AOR 0.11,95%CI 0.03-0.41)。
  • 随访电话完成88例(26.3%)。

证据类型、等级与局限

  • 证据类型:随机临床试验;原文未报告证据等级。
  • 局限:16周随访电话仅完成88例(26.3%),门诊指标解释受限;作者在结论中提出需更广泛的社区和区域合作以弯曲费用曲线。

对床旁实践的改变

  • 对于无现有门诊MOUD处方医生的阿片类使用障碍住院患者,转介至联合驻点桥接诊所未能缩短住院时长。
  • 桥接诊所转介可能改善门诊衔接和MOUD续方并减少过量,但伴随更高的资源使用和费用,作者认为弯曲费用曲线可能需要更广泛的社区和区域合作。

指南或共识出处

  • 临床试验注册号:ClinicalTrials.gov NCT04084392。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Co-located bridge clinics aim to facilitate a timely transition to outpatient care for inpatients with opioid use disorder (OUD); however, their effect on hospital length of stay (LOS) and postdischarge outcomes remains unclear.

OBJECTIVE: To evaluate the effect of a co-located bridge clinic on hospital LOS among inpatients with OUD.

DESIGN, SETTING, AND PARTICIPANTS: This parallel-group randomized clinical trial recruited 335 adult inpatients with OUD seen by an addiction consultation service and without an existing outpatient clinician to provide medication for OUD (MOUD) between November 25, 2019, and September 28, 2021, at a tertiary care hospital affiliated with a large academic medical center and its bridge clinic.

INTERVENTION: The bridge clinic included enhanced case management before and after hospital discharge, MOUD prescription, and referral to a co-located bridge clinic. Usual care included MOUD prescription and referrals to community health care professionals who provided MOUD.

MAIN OUTCOMES AND MEASURES: The primary outcome was the index admission LOS. Secondary outcomes, assessed at 16 weeks, were linkage to health care professionals who provided MOUD, MOUD refills, same-center emergency department (ED) and hospital use, recurrent opioid use, quality of life (measured by the Schwartz Outcome Scale-10), overdose, mortality, and cost. Analysis was performed on an intent-to-treat basis.

RESULTS: Of 335 participants recruited (167 randomized to the bridge clinic and 168 to usual care), the median age was 38.0 years (IQR, 31.9-45.7 years), and 194 (57.9%) were male. The median LOS did not differ between arms (adjusted odds ratio [AOR], 0.94 [95% CI, 0.65-1.37]; P = .74). At the 16-week follow-up, participants referred to the bridge clinic had fewer hospital-free days (AOR, 0.54 [95% CI, 0.32-0.92]), more readmissions (AOR, 2.17 [95% CI, 1.25-3.76]), and higher care costs (AOR, 2.25 [95% CI, 1.51-3.35]), with no differences in ED visits (AOR, 1.15 [95% CI, 0.68-1.94]) or deaths (AOR, 0.48 [95% CI, 0.08-2.72]) compared with those receiving usual care. Follow-up calls were completed for 88 participants (26.3%). Participants referred to the bridge clinic were more likely to receive linkage to health care professionals who provided MOUD (AOR, 2.37 [95% CI, 1.32-4.26]) and have more MOUD refills (AOR, 6.17 [95% CI, 3.69-10.30]) and less likely to experience an overdose (AOR, 0.11 [95% CI, 0.03-0.41]).

CONCLUSIONS AND RELEVANCE: This randomized clinical trial found that among inpatients with OUD, bridge clinic referrals did not improve hospital LOS. Referrals may improve outpatient metrics but with higher resource use and expenditure. Bending the cost curve may require broader community and regional partnerships.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04084392.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Marcovitz D, Dear ML, Donald R, et al. Effect of a Co-Located Bridging Recovery Initiative on Hospital Length of Stay Among Patients With Opioid Use Disorder: The BRIDGE Randomized Clinical Trial. JAMA Netw Open. 2024. PMID: 38411964. doi:10.1001/jamanetworkopen.2023.56430

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。